MIR-142-3P

There are 2 papers on MIR-142-3P in aging research: 1 trial in people, 1 in animals.

2 papers study it1 finding

See all 2 papers on MIR-142-3P

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

1 lab in 1 country

Funders: Major Research Plan and 1 more

Human trial1
Animals1

Effects

1

Osteoblast differentiation

downin mouse cells1

1 study

MIR-142-3P decreases osteoblast differentiation in aged BMSCs.
“diminished the osteogenic potential of BMSCs”
Cellsin aged BMSCs
Clock-modified mesenchymal stromal cells therapy rescues molecular circadian oscillation and age-related bone loss via miR142-3p/Bmal1/YAP signaling axis
Cell death discoveryMar 12, 2022

Latest

Cell Death DiscoveryMar 14

Clock-modified mesenchymal stromal cells therapy rescues molecular circadian oscillation and age-related bone loss via miR142-3p/Bmal1/YAP signaling axis

Experiments in miceBone loss

Frontiers in PhysiologyAug 20

Physical Activity as a Preventive Lifestyle Intervention Acts Through Specific Exosomal miRNA Species-Evidence From Human Short- and Long-Term Pilot Studies

Non-randomized trial in 14 peopleInterventions